Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	328.00B
Revenue (ttm)	602.21B
Net Income (ttm)	35.75B
Shares Out	11.65M
EPS (ttm)	2,985.83
PE Ratio	9.43
Forward PE	n/a
Dividend	630.00 (2.25%)
Ex-Dividend Date	Nov 24, 2025

Volume	14,936
Average Volume	25,495
Open	28,300
Previous Close	28,150
Day's Range	27,650 - 28,300
52-Week Range	21,800 - 32,200
Beta	0.07
RSI	43.40
Earnings Date	Feb 11, 2026

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.